ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,107.60
0.99%
Dow Jones
39,721.36
1.09%
Brent Oil
85.385
0.39%
Bitcoin
57,828.40
0.12%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. Journey Energy Inc (JOY) Quote

Journey Energy Inc

Journey Energy Inc (JOY)

TSX
3.00
0.05
(1.69%)
Closed July 11 4:12PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
3.00
Bid
2.98
Ask
3.00
Volume
49,031
2.92 Day's Range 3.01
2.91 52 Week Range 6.11
Market Cap
177.915M
Previous Close
2.95
Open
2.95
Last Trade
100
@
3
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
106,371
Shares Outstanding
60,310,000
Dividend Yield
-
PE Ratio
11.44
Earnings Per Share (EPS)
0.26
Revenue
186.92M
Net Profit
15.82M

About Journey Energy Inc

Sector
Crude Petroleum & Natural Gs
Industry
Crude Petroleum & Natural Gs
Website
www.journeyenergy.ca
Headquarters
Calgary, Alberta, Can
Founded
1970
Journey Energy Inc is listed in the Crude Petroleum & Natural Gs sector of the Toronto Stock Exchange with ticker JOY. The last closing price for Journey Energy was $2.95. Over the last year, Journey Energy shares have traded in a share price range of $ 2.91 to $ 6.11.

Journey Energy currently has 60,310,000 shares outstanding. The market capitalization of Journey Energy is $177.91 million. Journey Energy has a price to earnings ratio (PE ratio) of 11.44.

JOY Latest News

More News

JOURNEY ENERGY INC. ANNOUNCES $38 MILLION "BOUGHT DEAL" PRIVATE PLACEMENT OFFERING

JOURNEY ENERGY INC. ANNOUNCES $38 MILLION "BOUGHT DEAL" PRIVATE PLACEMENT OFFERING Canada NewsWire CALGARY, AB, March 5, 2024 /NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR...

March 05 2024
PR Newswire (Canada)

Journey Energy Inc. Announces Year-End 2023 Reserves

CALGARY, Alberta, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Journey Energy Inc. (JOY – TSX) (“Journey” or the “Company”) is pleased to report its year-end 2023 oil and gas reserves evaluation. 2023...

February 22 2024
GlobeNewswire Inc.

JOURNEY ENERGY PROVIDES UPDATE ON 2023 CAPITAL PROGRAM; PROVIDES 2024 PRELIMINARY GUIDANCE INCLUDING STAGGERED PAYMENT OF TERM DEBT

JOURNEY ENERGY PROVIDES UPDATE ON 2023 CAPITAL PROGRAM; PROVIDES 2024 PRELIMINARY GUIDANCE INCLUDING STAGGERED PAYMENT OF TERM DEBT Canada NewsWire CALGARY, AB, Dec. 21, 2023 CALGARY, AB, Dec...

December 21 2023
PR Newswire (Canada)

JOURNEY POSTS $7.7 MILLION OF NET INCOME IN THE THIRD QUARTER OF 2023; INITIATES 2023 DRILLING PROGRAM WITH ABOVE TYPE CURVE RESULTS

JOURNEY POSTS $7.7 MILLION OF NET INCOME IN THE THIRD QUARTER OF 2023; INITIATES 2023 DRILLING PROGRAM WITH ABOVE TYPE CURVE RESULTS Canada NewsWire CALGARY, AB, Nov. 7, 2023 CALGARY, AB, Nov. 7...

November 07 2023
PR Newswire (Canada)

JOURNEY ANNOUNCES SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS

JOURNEY ANNOUNCES SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS Canada NewsWire CALGARY, AB, Aug. 8, 2023 CALGARY, AB, Aug. 8, 2023 /CNW/ - Journey Energy Inc. (TSX: JOY) (OTCQX: JRNGF...

August 08 2023
PR Newswire (Canada)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.07-2.280130293163.073.152.91626063.02502669CS
4-0.26-7.97546012273.263.322.91900093.02781731CS
12-0.57-15.96638655463.573.942.911063713.35503051CS
26-0.71-19.13746630733.714.082.911149343.44201302CS
52-2.54-45.84837545135.546.112.911204094.2715289CS
1561.4593.54838709681.557.941.062783785.02010904CS
2600.5202.57.940.061889114.66498325CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KZIAKazia Therapeutics Ltd
$ 0.6509
(239.01%)
450.24M
IVPInspire Veterinary Partners Inc
$ 8.11
(130.40%)
29.26M
NBSTWNewbury Street Acquisition Corporation
$ 0.0998
(66.33%)
3.1k
CYCNCyclerion Therapeutics Inc
$ 3.81
(65.64%)
18.89k
CINGCingulate Inc
$ 0.5996
(61.05%)
1.24M
ZAPPZapp Electric Vehicles Group Ltd
$ 9.40
(-47.63%)
9.97M
SISIShineco Inc
$ 2.49
(-44.79%)
1.59M
CVRXCVRx Inc
$ 7.18
(-38.26%)
2.04M
ICUSeaStar Medical Holding Corporation
$ 8.07
(-37.92%)
1.12M
TOIIWOncology Institute Inc
$ 0.0185
(-31.23%)
2.57k
KZIAKazia Therapeutics Ltd
$ 0.6509
(239.01%)
450.24M
NVDANVIDIA Corporation
$ 134.91
(2.69%)
248.96M
MAXNMaxeon Solar Technologies Ltd
$ 0.2078
(-16.21%)
246.5M
TSLATesla Inc
$ 263.26
(0.35%)
128.52M
VRPXVirpax Pharmaceuticals Inc
$ 1.68
(44.83%)
117.18M

Discussion

View Full Feed
doc063 doc063 5 minutes ago
I'm seeing all of the attention on RNVA and not FOXO on IHub.

Something to make us all think about what's cooking in the background.
FOXO RNVA
somberfox somberfox 5 minutes ago
Nah man, we're gonna get a watch, you know, the thing that's never used in 2024, save for Garmins/fitbits.
RONN
Lazarus Lazarus 6 minutes ago
Just dropped in to make sure you're still holdin' down the fort here.

This from the book of Ecclesiasticus [chapter 38]:

Honour a physician with the honour due unto him for the uses which ye may have of him: for the Lord hath created him.

For of the most
chereb19 chereb19 6 minutes ago
Direct Interstitial Injection: An Approach to Optimizing Therapeutic Ratios for Safe and Effective Delivery of High-dose Radionuclide Therapy in Treating Solid Tumors (P446)
Mon, July 08
Gatlin C/D
Poster Session

Part of:
Poster Session 1
Info
RDGL
LetGoodTimesRoll LetGoodTimesRoll 8 minutes ago
$RNVA==>$FOXO ===>NYSE====>$$$$$$$
FOXO RNVA
GoodGuyBill GoodGuyBill 8 minutes ago
And your comment... ROTFLMAO!!!!

Your entire comment is simply no more than a speculative wish list, akin to a child writing to santa, in the hope of getting a new bike 🚲 ☝️🥴
NWBO
Lazarus Lazarus 11 minutes ago
oops / duplicate
Lazarus Lazarus 11 minutes ago
My late brother had a RX filled incorrectly and I think he had a bad reaction. I'm not sure who his attorney sued - doctor or pharmacist - but he got something like $30k as a result. This was around 45 years ago
Vexari Vexari 12 minutes ago
The cartel

Has no remorse
janice shell janice shell 12 minutes ago
Does anyone know what really happened during Donald Trumps trial?

You really are a dimwit. A dimwit without a television, it seems. All the networks had people in the courtroom transcribing what happened at the trial. And yes, there was an official steno, who produced official transcr
littlejohn littlejohn 13 minutes ago
TSLA - China - bicycles - rising EV sales

by China companies in 2024 are

still putting margin pressure on TSLA...

Bicycles are still owned by most China

folks in case the power goes out,

so the EVs adapting better in China ar
SQQQ TSLA
BDEZ BDEZ 18 minutes ago
TX moves to ban Sharia Law

https://x.com/FarmGirlCarrie/status/1811134301075013781
mikepgator mikepgator 21 minutes ago
Wow nice last minute of trading!
RDGL
Lazarus Lazarus 23 minutes ago
RE: > perhaps...
ooooooh. you dont say?
RJDG
ATLnsider ATLnsider 23 minutes ago
meirluc, I respect your opinion, but I still disagree that there would be any need or added benefit to add SurVaxM to DCVax-L.

DCVax-L already targets survivin, plus hundreds of other antigens, peptides and biomarkers. I will stick with what Dr. Linda Liau and Dr. Robert Prins study r
NWBO
BDEZ BDEZ 25 minutes ago
Welfare costs exploding in Germany

https://x.com/ramzpaul/status/1811041484558283128

Sound familiar?
XMaster2023 XMaster2023 25 minutes ago
Pump, this is small PRE revenue biotech firm. DCVax-L will be their ONLY approved product. What the hell did you expect? Blood from a turnip?
This said approval and revenue are just around the corner. Your boss can shove it!
NWBO
F4Uvet F4Uvet 26 minutes ago
Bravery has nothing to do with the barking dog. The dog was only voicing his opinion regarding the stupidity of the lion's death which was the result of his overwhelming avarice.
MXSG
Tadaaa Tadaaa 31 minutes ago
The enemy does their best work in the Principalities:

-Education
-Politics
-Religion
-Economics
-Propaganda

We war not against flesh and blood but against spiritual wickedness in high places.

Researchfyi Researchfyi 33 minutes ago
Many consumers own smart watches and other smart products used for health related tracking. But, ironically none of them unless used for a specific function like diabetes have FDA approval.

I believe FDA approval for the purposes of sales is a very strategic competitive factor and hug
LQMT
rooster rooster 33 minutes ago
I’m a mechanical contractor who only installs new plumbing and hvac systems
ducci1 ducci1 33 minutes ago
Pivot Calcs: SPX Pivot--5618----R1--5651----R2--5667----R3--5700-----S1--5602----S2--5569----S3--5552 !
SPY
LOB LOB 33 minutes ago
Read some things on AXXA Twitter (X) the last two weeks that say they were just completing the audit. It was about the first or 2nd or third of July. They said they were just finishing it up and would be done in a few days. Done deal. That could be why the earnings release is Monday not this week..
AXXA
skitahoe skitahoe 35 minutes ago
If I recommend a stock to a friend at $1 and say it's a long term hold, if the stock goes to $.50 and I'm still recommending it, am I responsible in any way if my friend gets impatient and sells at a loss. I don't believe that's the case as long as my advice is to hold the stock and buy more if you
NWBO

Your Recent History

TSX
JOY
Journey Energy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved